• Monthly Archives: May 2014

    Netmums: An Internet-Based Intervention for Women with Postpartum Depression

    While postpartum depression (PPD) affects about 10%-15% of women, most women with PPD do not receive any treatment.  Over the last decade, we have made progress in increasing awareness of postpartum mental health issues; however, there are still significant obstacles to obtaining treatment.  Women are not able to find appropriate treaters or cannot access care in a timely fashion, especially in more remote areas.  They may not have reliable childcare and thus cannot attend their own appointments.  Or they may simply be too depressed or anxious to leave their homes.

    The Effects of Yoga and Exercise on Menopausal Quality of Life

    Many women transitioning into the menopause request medical advice on ways to improve their quality of life and to relieve the symptoms associated with the menopausal transition. With concerns regarding the long-term use of estrogen replacement therapy, there has been interest in the use of non-hormonal strategies to manage these symptoms.

    Pregnancy and Marijuana: How Much Do We Really Know?

    With many states now considering the legalization of medical marijuana, there seems to be a growing sense that marijuana is relatively safe and may, in some cases, be more attractive or effective than traditional pharmacologic interventions.  We have witnessed this shift in attitude in our clinic, where many of our clinicians have been surprised to hear women ask questions about the dangers of using antidepressants and other medications during pregnancy while at the same time feeling relatively comfortable with their use of marijuana in the same setting.

    Latest News From the National Pregnancy Registry

    We would like to thank you for your continuing support of the National Pregnancy Registry for Atypical Antipsychotics (NPRAA) at the Center for Women’s Mental Health at Massachusetts General Hospital. We are grateful for all the referrals made to the Registry as our numbers continue to grow every day. Given the Registry’s successful enrollment, we are pleased to announce our plan to release preliminary data at an upcoming conference in June, the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.

    Go to Top